| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020073 Use of oligosaccharides to stimulate beta-endorphin production |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019975 Novel Regimens for Treating Diseases and Disorders |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019940 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| 01/24/2008 | DE102006033140A1 Aminoindazolharnstoffderivate Aminoindazolharnstoffderivate |
| 01/24/2008 | DE102006033114A1 Spirocyclische Azaindol-Derivate Spirocyclic azaindole derivatives |
| 01/24/2008 | CA2658433A1 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
| 01/24/2008 | CA2658361A1 Ophthalmic formulations for the treatment of inflammation |
| 01/24/2008 | CA2658327A1 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 01/24/2008 | CA2657776A1 Triazolyl phenyl benzenesulfonamides |
| 01/24/2008 | CA2657269A1 New indications for direct thrombin inhibitors |
| 01/24/2008 | CA2657114A1 Nf-.kappa.b inhibitor |
| 01/23/2008 | EP1881065A1 DINO polypetide |
| 01/23/2008 | EP1881007A1 LLR-J24 related proteins |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1879891A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity |
| 01/23/2008 | EP1879597A2 Lipid a analogs for treating oral and gastrointestinal mucositis |
| 01/23/2008 | EP1879565A2 Topical pharmaceutical formulation containing nimesulide |
| 01/23/2008 | EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 01/23/2008 | EP1673086B1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1347768B1 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1268425B1 Carbamate caspase inhibitors and uses thereof |
| 01/23/2008 | EP1257281B8 Nucleoside analogs with carboxamidine modified monocyclic base |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111521A Humanized antibody specific for tumor necrosis factor-alpha |
| 01/23/2008 | CN101111495A Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101108243A Method of preparing traditional chinese medicine formulated product for treating rheumatism paralysis |
| 01/23/2008 | CN101108226A Medicament treating rheumatism, rheumatoid, woman's wind, osteoproliferation and slipped disc illness |
| 01/23/2008 | CN101108224A Plants natural base extractive and formulated product and use thereof |
| 01/23/2008 | CN101108219A Method of preparing traditional Chinese medicine formulated product for treating gastroenteritis |
| 01/23/2008 | CN101108212A Pharmaceutical composition for treating paralysis |
| 01/23/2008 | CN101108197A Total polyoses from inula flower and use in regulating or treating diabetes and complication and immunoregulation |
| 01/23/2008 | CN101108193A Water-solubility rutoside and method of manufacturing the same and oral preparation |
| 01/23/2008 | CN101108190A Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease |
| 01/23/2008 | CN101108185A Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 01/23/2008 | CN101108171A Budesonide intestines sustained release dextromethorphan pellets and method of manufacturing the same |
| 01/23/2008 | CN101108170A Aceclofenac in extended-released tablets and method of manufacturing the same |
| 01/23/2008 | CN101108165A Capsicine microemulsion and microemulsion gel rubber |
| 01/23/2008 | CN101108016A Coptis, phellodendron and scutellaria beverage for fire-purging |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363037C Medicine for treating rheumarthritis and traumatic injury pain and its prpen |
| 01/23/2008 | CN100363033C Medicine for treating pain caused by wind, cold and wetness evils and its prepn |
| 01/23/2008 | CN100363032C Eggplant root extract and its preparing method and use |
| 01/23/2008 | CN100363025C Method for preparing aconturm fischeri mankshood |
| 01/23/2008 | CN100363019C Cervus and cucumis polypeptide injection composition and preparing method |
| 01/23/2008 | CN100363018C Honeysuckle flower soft capsule and preparation method thereof |
| 01/23/2008 | CN100363014C Gugua polypeptide medicinal composition for injetion and preparing method therefor |
| 01/23/2008 | CN100362986C Dry powder inhalant composition |
| 01/22/2008 | US7321059 2,3-diethoxylated propionic acid derivatives, e.g., 20-(7,10,13,16-tetraoxaheptadec-1-yloxy)-2,5,8,11,18-pentaoxahenicosan-21-oic acid; for use in inhalation therapy with propellants for treating respiratory system disorders |
| 01/22/2008 | US7321041 1,6 Naphthyridines useful as inhibitors of SYK kinase |
| 01/22/2008 | US7321040 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders |
| 01/22/2008 | US7321026 Framework-patched immunoglobulins |
| 01/22/2008 | US7320992 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use |
| 01/22/2008 | US7320987 2,6-disubstituted 7-oxo-pyrido[2,3-d]pyrimidines; inhibition of LPS-induced Tumor Necrosis Factor- alpha production in THP1 cells |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320980 Substituted pyrido(1,2-a)pyrimidines and their use as NOS inhibitors |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320873 for diagnosing autoimmune disease (rheumatoid arthritis) activity using monoclonal antibodies |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320784 Metal support surface, conjugate releasably bound to the support surface, the conjugate comprising a ligand and a targeting molecule;wherein the conjugate coordinates with a complex-forming metal ion so that labeled conjugate is released; radiotherapy and as imaging agents in medical diagnostics |
| 01/22/2008 | CA2431515C Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition, and use thereof |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2338728C Pharmaceutical composition for injection based on paracetamol |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2293589C Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 01/22/2008 | CA2283101C Quinoline leukotriene antagonists |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/21/2008 | CA2594196A1 Protease inhibiting polymer |
| 01/17/2008 | WO2008008453A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 01/17/2008 | WO2008007997A1 External application anti-inflammatory agent |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008006794A1 Indole compounds having affinity to the ep1 receptor |
| 01/17/2008 | WO2008006793A1 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006663A1 2-arylindole derivatives as npges-i inhibitors |
| 01/17/2008 | WO2008006589A2 Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 01/17/2008 | WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | WO2008006582A1 Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases |
| 01/17/2008 | WO2008006480A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 01/17/2008 | WO2008006369A1 Adenosine receptor antagonists |
| 01/17/2008 | WO2008006226A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007112000A3 Treatment of pain |
| 01/17/2008 | WO2007108004A3 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases |
| 01/17/2008 | WO2007100617A3 Imidazole-based compounds, compositions comprising them and methods of their use |